Policy and Advocacy
When Grants End, So Do Scientific Breakthroughs
New analysis from amfAR’s Public Policy Office assesses the human cost of terminated federal research grants focused on cancer.
Your Source for HIV Data
amfAR maintains a series of free interactive databases to inform policymakers, public health officials, advocates, researchers, and other stakeholders about key aspects of the evolving U.S. and global HIV epidemics. These essential resources provide comprehensive data on global HIV programming/funding, key populations, the opioid epidemic, COVID-19, and the U.S. Ending the Epidemic plan.
New Agreements for Funding Global HIV Program Miss the Mark
A new amfAR report analyzes how the new Global Health MOUs fail to establish metrics to measure their success.
For Long-Term Survivors, HIV Is Just a Piece of the Puzzle
amfAR Trustee Phill Wilson reflects on his journey living with HIV for over four decades—his personal losses, his HIV advocacy, and staying on top of his health as he ages.
Focus on Key Populations Remains Integral to the HIV Response
A new amfAR report affirms the importance of investing in prevention services that target key populations to decrease new HIV infections.